Prescription Drug Importation

McClellan to lead study of drugs from Canada, over objections

Published in State and Local Health Law Weekly, March 18th, 2004

U.S. Department of Health and Human Services Secretary Tommy Thompson named the U.S. Food and Drug Administration Commissioner Mark McClellan, a vocal opponent of importing drugs from Canada, to lead a government study of the issue.

The study is required by the new Medicare law, which left in place the government's ban on bringing in cheaper prescription drugs from Canada. Thompson promised the study would be balanced. Led by McClellan, the Food and Drug Administration (FDA) has repeatedly said it opposes importing drugs because it cannot guarantee they are safe.

The decision to nominate McClellan to lead the agency that runs Medicare provoked strong...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of State and Local Health Law Weekly

Source: State and Local Health Law Weekly (2004-03-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry